Health Care Counsel Blog
418 total results. Page 1 of 17.
With COVID-19 rates again rising rapidly among unvaccinated individuals, California health care and government leaders are pushing to increase vaccination rates for healthcare workers in the state.
Expanded telehealth services temporarily permitted during the COVID-19 public health emergency would be further extended to December 21, 2023, in order for CMS to conduct analyses regarding permanent expansion of certain telehealth services.
Physician Fee Schedule Proposed Rule for 2022 Released: What Pharmaceutical Manufacturers Need to Know
The Centers for Medicare & Medicaid Services (CMS) calendar year 2022 rule proposing changes to payment policies under the Physician Fee Schedule (PFS) and Medicare Part B (the Proposed Rule) will officially be published in the Federal Register on July 23, 2021.
On July 19, 2021, the Secretary of Health and Human Services (HHS) renewed the declaration of the COVID-19 Public Health Emergency (PHE), effective July 20, 2021.
On July 1, 2021, the Departments of Health and Human Services, Labor, and Treasury, and the Office of Personnel Management, released a much-anticipated interim final rule designed to protect Americans from surprise medical bills.
In this clip from our webinar, “Legal and Operational Considerations for Healthcare Employers During This Ever Changing Time of COVID and Vaccines,” Health Care Partner Jill Steinberg addresses the operational and regulatory concerns of mandating the COVID-19 vaccine.
The United States Supreme Court has agreed to hear a case that has a direct impact on the 340B Drug Discount Program (the 340B Program) and how Medicare will reimburse hospitals for dispensing of 340B covered drugs, as well as other reimbursement issues.
Our panel kicks off the “Legal and Operational Considerations for Healthcare Employers During This Ever Changing Time of COVID and Vaccines” webinar with this timely question.
Our panel offers insight on providing incentives vs. mandating the COVID-19 vaccine during the “Legal and Operational Considerations for Healthcare Employers During This Ever Changing Time of COVID and Vaccines” webinar.
Take note, all providers who received Provider Review Fund (PRF) payments – there are changes in the reporting deadlines and requirements.
On March 31, 2021, New York Governor Andrew Cuomo signed the Marijuana Regulation and Taxation Act (MRTA) into law, legalizing adult-use cannabis in the state and establishing a regulatory framework to govern what likely will be one of the nation’s largest cannabis markets.
Los Angeles Partner Debra Albin-Riley recently argued before the California Supreme Court in a closely-watched case involving the scope of anti-SLAPP protection for medical staff peer review.
The Minnesota Department of Health (MDH) will host a public, virtual meeting on Thursday, June 10, 2021, at 1 p.m. Central time to present and request feedback on draft reporting guidelines for the Minnesota Prescription Drug Price Transparency Act (Minnesota Statutes 62.J.84).
Join Arent Fox Partner Anne Murphy as she moderates a panel on Emerging Governance Issues for health care organizations.
Health Care Partner Debra Albin-Riley and Counsel Sarah Benator will present a webinar for the California Society for Healthcare Attorneys (CSHA) on May 26, 2021.
Several recent surveys and reports by governance and trade associations provide a useful overview of the duties, roles, challenges, and internal relationships of the corporate general counsel, as well as governing board needs and priorities.
As EMS Assumes a More Diversified Role in Health Care Delivery, Ambulance Service Compliance Takes Center Stage
In recent years, the emergency medical services (EMS) sector has assumed a more central role in health care delivery, including care in the home and, in some cases, emergency department visit prevention.
Applicable drug manufacturers and group purchasing organizations that are subject to the reporting rules under the Open Payments System are reminded that March 31, 2021, is the final day to submit and attest to data for the June 2021 publication of Program Year 2020 data.
Texas Health and Human Services announced that beginning April 1, 2021, drug manufacturers who wish for their products to be added to the Texas Drug Code Index (the Texas Medicaid formulary) must create an electronic account.
Health Resources and Services Administration Enjoined from Implementing the 340B Dispute Resolution Rule
Immediately at issue was Lilly and Company and Lilly USA’ refusal to sell covered outpatient drugs at the 340B Ceiling Price to contract pharmacies acting as agents for 340B Covered Entities. Several 340B Covered Entities had petition for a hearing by the ADR panel.
Passage of American Rescue Plan Act of 2021 Could Mean Larger Medicaid Drug Rebate Program Rebates for Pharmaceutical Manufacturers
The American Rescue Plan Act of 2021, signed into law by President Biden on March 11, 2021, is a $1.9 trillion aid package that provides assistance to businesses and individuals experiencing financial hardship due to COVID-19.
Douglas A. Grimm, FACHE, Anne M. Murphy, Diane Roldán, Jill A. Steinberg, Rachel Hold-Weiss, Stephanie Trunk, Thomas E. Jeffry, Jr., Candace C. Sandoval, Michele L. Gipp, Erin E. Atkins, Hillary M. Stemple
Our Health Care team has a complete analysis of recent updates to the Stark Law and Anti-Kickback Statute and their impact on health care providers.